Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of this randomized trial is to investigate the efficacy and toxicity of percutaneous high-dose radiotherapy in patients with oligometastases of hormone refractory prostate cancer. The effectiveness will be tested in comparison to an observation group, in which no further therapy is initially given. Treatment can be stereotactically hypofractionated or conventionally fractionated.
Epistemonikos ID: f1969775e4b4a44ee1ac62aaf21b6ef75173c280
First added on: May 06, 2024